Ratios of CD4+CXCR3+/CD4+CCR4+ and CD4+CXCR3+/CD4+CCR3+ were higher in MS patients than HC, which also indicates Th1 dominance in balancing Th1/Th2 responses. Here, CXCR3 is linked to myeloid sarcoma.